Advertisement

PharmacoEconomics

, Volume 27, Issue 1, pp 11–24 | Cite as

Is Medication Review by Primary-Care Pharmacists for Older People Cost Effective?

A Narrative Review of the Literature, Focusing on Costs and Benefits
  • Arnold G. ZermanskyEmail author
  • Jonathan Silcock
Review Article

Abstract

The nature, definition and history of medication review of long-term conditions and treatment is discussed. A literature search for studies of medication review of older people in primary care by pharmacists yielded 16 reports of studies in English, and only ten of these were randomized controlled trials. Extracting meaningful conclusions from the data was problematic because of variations in the nature of the review described, the populations studied, the outcome data measured and the evaluation criteria used. There is a dearth of economic measurement and often inadequate descriptions of the interventions performed. Those interventions that were described in detail varied in the skills, training and approach of the pharmacists. Therefore, there was no possibility of aggregating results of studies, and the review conclusions are based on trends and impression rather than meta-analysis.

There was no suggestion in any reports that patients were harmed by the interventions, and some consistency in suggesting that falls and hospital admissions might be reduced with modest cost savings, at least in terms of drug costs. No studies reported a benefit in terms of mortality, mental capacity or activities of daily living. The authors conclude that clinical medication review is probably of value and may be cost effective, but propose a large-scale, longterm, multicentre, collaborative clinical trial with carefully chosen (and clearly described) interventions and outcome measures to confirm this.

Keywords

Nursing Home Nursing Home Resident Medication Review Inappropriate Medication Pharmacist Intervention 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

No sources of funding were used to assist in the preparation of this review.

A. Zermansky has been involved in the development and execution of two major clinical trials of chemical medication review by pharmacists. The authors have no other conflicts of interest that are directly relevant to the content of this review.

References

  1. 1.
    Office for National Statistics. Prescriptions dispensed in the community: statistics for 1996 to 2006 England. Leeds: NHS Information Centre, 2007Google Scholar
  2. 2.
    Horne R, Weinman J, Barber N, et al. Concordance, adherence and compliance in medicine taking: report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D. London: NCCSDO, 2005Google Scholar
  3. 3.
    Cartwright A, Smith C. Elderly people, their medicines and their doctors. London: Routledge, 1988Google Scholar
  4. 4.
    Zermansky AG. Who controls repeats? Br J Gen Pract 1996; 46 (412): 643–7PubMedGoogle Scholar
  5. 5.
    Petty DR, House A, Knapp P, et al. Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing 2006; 35 (5): 523–6PubMedCrossRefGoogle Scholar
  6. 6.
    Balint M, Joyce D, Marinker M, et al. Treatment or diagnosis: a study of repeat prescriptions. London: Tavistock, 1970Google Scholar
  7. 7.
    Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151 (9): 1825–32PubMedCrossRefGoogle Scholar
  8. 8.
    Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med 2002; 162 (15): 1670–2PubMedCrossRefGoogle Scholar
  9. 9.
    Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370 (9582): 173–84PubMedCrossRefGoogle Scholar
  10. 10.
    Arnold M. The future. In: Empedocles on Etna, and other poems. London: Fellowes B, 1852Google Scholar
  11. 11.
    Shaw J, Seal R, Pilling M. Room for review: a guide to medication review. The agenda for patients, practitioners and managers. London: Medicines Partnership, 2002Google Scholar
  12. 12.
    Lowe CJ, Petty DR, Zermansky AG, et al. Development of a method for clinical medication review by a pharmacist in general practice. Pharm World Sci 2000; 22 (4): 121–6PubMedCrossRefGoogle Scholar
  13. 13.
    Briesacher B, Limcangco R, Simoni-Wastila L, et al. Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment. J Am Geriatr Soc 2005; 53 (6): 991–6PubMedCrossRefGoogle Scholar
  14. 14.
    Christensen D, Trygstad T, Sullivan R, et al. A pharmacy management intervention for optimizing drug therapy for nursing home patients. Am J Geriatr Pharmacother 2004; 2: 248–56PubMedCrossRefGoogle Scholar
  15. 15.
    Denneboom W, Dautzenberg MGH, Grol R, et al. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Pract 2007; 57 (542): 723–31PubMedGoogle Scholar
  16. 16.
    Fahey T, Montgomery AA, Barnes J, et al. Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ 2003; 326 (7389): 580–4PubMedCrossRefGoogle Scholar
  17. 17.
    Furniss L, Lloyd Craig SK, Scobie S, et al. Effects of a pharmacist’s medication review in nursing homes: randomised controlled trial. Br J Psychiatry 2000; 176: 563–7PubMedCrossRefGoogle Scholar
  18. 18.
    Burns A, Furniss L, Cooke J, et al. Pharmacist medication review in nursing homes: a cost analysis. Int J Geriatr Psychopharmacol 2000; 2 (3): 137–41Google Scholar
  19. 19.
    Holland R, Lenaghan E, Harvey I, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005; 330 (7486): 293–7PubMedCrossRefGoogle Scholar
  20. 20.
    Haumschild MJ, Karfonta TL, Haumschild MS, et al. Clinical and economic outcomes of a fall-focused pharmaceutical intervention program. Am J Health Syst Pharm 2003; 60 (10): 1029–32PubMedGoogle Scholar
  21. 21.
    Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30 (3): 205–11PubMedCrossRefGoogle Scholar
  22. 22.
    Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care: the POLYMED randomised controlled trial. Age Ageing 2007; 36 (3): 292–7PubMedCrossRefGoogle Scholar
  23. 23.
    Lipton HL, Bero LA, Bird JA, et al. The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing: a randomized controlled trial. Medical Care 1992; 30 (7): 646–58PubMedCrossRefGoogle Scholar
  24. 24.
    Malone DC, Carter BL, Billups SJ, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000; 20 (10): 1149–58PubMedCrossRefGoogle Scholar
  25. 25.
    Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51 (3): 257–65PubMedCrossRefGoogle Scholar
  26. 26.
    Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 2003; 12 (3): 176–80PubMedCrossRefGoogle Scholar
  27. 27.
    Sorensen L, Stokes JA, Purdie DM, et al. Medication reviews in the community: results of a randomized, controlled effectiveness trial [published erratum appears in Br J Clin Pharmacol 2005; 59 (3): 376]. Br J Clin Pharmacol 2004; 58 (6): 648–64PubMedCrossRefGoogle Scholar
  28. 28.
    Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323 (7325): 1340–3PubMedCrossRefGoogle Scholar
  29. 29.
    Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006; 35 (6): 586–91PubMedCrossRefGoogle Scholar
  30. 30.
    Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157 (14): 1531–6PubMedCrossRefGoogle Scholar
  31. 31.
    Office of Fair Trading. Care homes for older people in the UK: a market study. London: OFT, 2005 [online]. Available from URL: http://www.oft.gov.uk/shared_oft/reports/consumer_protection/oft780.pdf [Accessed 2008 Oct 29]
  32. 32.
    Bajekal M. Health survey for England 2000: care homes and their residents. London: The Stationery Office, 2002Google Scholar
  33. 33.
    Zermansky AG, Freemantle N. Is medication review by pharmacists of any use? Pharmacoeconomics 2007; 25 (2): 91–2PubMedCrossRefGoogle Scholar
  34. 34.
    Department of Health. National service framework for older people. London: The Stationery Office, 2001Google Scholar

Copyright information

© Adis Data Information BV 2009

Authors and Affiliations

  1. 1.School of HealthcareUniversity of LeedsLeedsUK

Personalised recommendations